Pharmacological approaches to the treatment of obstructive sleep apnoea (Q56335829)

Expert Opinion on Investigational Drugs

Europe PubMed Central

title

Pharmacological approaches to the treatment of obstructive sleep apnoea (English)

0 references

1 reference

John R Stradling

3

0 references

Malcolm Kohler

series ordinal

1

object named as

Malcolm Kohler

0 references

Konrad E. Bloch

series ordinal

2

object named as

Konrad E Bloch

0 references

language of work or name

English

0 references

publication date

24 April 2009

0 references

published in

0 references

volume

18

0 references

issue

5

0 references

page(s)

647-656

0 references

cites work

Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

A predictive morphometric model for the obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Epidemiology of obstructive sleep apnea: a population health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Sympathetic neural mechanisms in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Elevated C-reactive protein in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Endothelial Function in Obstructive Sleep Apnea and Response to Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

CPAP and measures of cardiovascular risk in males with OSAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Pharmacological treatment of sleep apnea: current situation and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Compliance with nasal CPAP can be improved by simple interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

A randomized, controlled crossover trial of two oral appliances for sleep apnea treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Side effects of mandibular advancement devices for sleep apnea treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Surgical options for treatment of snoring and sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Maintenance of wakefulness test in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Tricyclic antidepressants (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Protriptyline in obstructive sleep apnea: a double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Serotonergic stimulation of the genioglossus and the response to nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Buspirone, an anxiolytic drug that stimulates respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Contribution of cholinergic systems to state-dependent modulation of respiratory control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Reduction of sleep-disordered breathing after physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Theophylline in obstructive sleep apnea. A double-blind evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Does nasal decongestion improve obstructive sleep apnea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Obstructive Sleep Apnea and Hypopnea Efficacy and Safety of a Long-Acting beta2-Agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Effect of surfactant on pharyngeal mechanics in sleeping humans: implications for sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Effect of Clonidine in Obstructive Sleep Apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Chronic treatment with sabeluzole protects cultured rat brain neurons from the neurotoxic effects of excitatory amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Randomized placebo-controlled trial of pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

Longitudinal study of moderate weight change and sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674

The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902877674